Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery (DO NOT EDIT)[1]
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery (DO NOT EDIT)[1]
Coronary artery bypass surgery hormonal manipulation
| Class I
|
| “1. Use of continuous intravenous insulin to achieve and maintain an early postoperative blood glucose concentration less than or equal to 180 mg/dL while avoiding hypoglycemia is indicated to reduce the incidence of adverse events, including deep sternal wound infection, after CABG (Level of Evidence: B)”
|
| Class IIb
|
| “1. The use of continuous intravenous insulin designed to achieve a target intraoperative blood glucose concentration less than 140 mg/dL has uncertain effectiveness (Level of Evidence: B)”
|
References
References
Template:WH
Template:WS
